Zymeworks (ZYME) had its price target raised by Stifel Nicolaus from $40.00 to $47.00. They now have a "buy" rating on the stock.
Zymeworks (ZYME) had its price target raised by Leerink Partners from $52.00 to $58.00. They now have an "outperform" rating on the stock.
Zymeworks outlines $1.5B milestone potential and signals milestone-driven expansion strategy through 2028 [Seeking Alpha]
Zymeworks Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Zymeworks Q4 Earnings Call Highlights [Yahoo! Finance]